Boston Scientific Corporation (BSX) Q4 2025 (USD): adj. EPS 0.80 (exp. 0.78), Revenue 5.29bln (exp. 5.28bln)
Importance
Level 1
GUIDANCE:
- Q1 Rev. growth view +10.5-12.0% (exp. 5.21bln)
- FY EPS view 3.43-3.49 (exp. 3.47)
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#BOSTON SCIENTIFIC CORP#BSX.US#FOREX#EQUITIES#METALS#EU SESSION#HEALTH CARE EQUIPMENT#METALS & MINING#HEALTH CARE EQUIPMENT & SUPPLIES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#BSX#DXY#US EQUITIES